首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5235篇
  免费   370篇
  国内免费   393篇
  2024年   5篇
  2023年   73篇
  2022年   160篇
  2021年   266篇
  2020年   183篇
  2019年   221篇
  2018年   217篇
  2017年   166篇
  2016年   224篇
  2015年   303篇
  2014年   389篇
  2013年   417篇
  2012年   467篇
  2011年   399篇
  2010年   253篇
  2009年   233篇
  2008年   261篇
  2007年   190篇
  2006年   183篇
  2005年   194篇
  2004年   167篇
  2003年   160篇
  2002年   116篇
  2001年   121篇
  2000年   89篇
  1999年   107篇
  1998年   53篇
  1997年   37篇
  1996年   42篇
  1995年   40篇
  1994年   34篇
  1993年   22篇
  1992年   30篇
  1991年   24篇
  1990年   31篇
  1989年   8篇
  1988年   17篇
  1987年   12篇
  1986年   9篇
  1985年   8篇
  1984年   10篇
  1983年   8篇
  1982年   7篇
  1981年   5篇
  1980年   6篇
  1979年   3篇
  1978年   3篇
  1977年   3篇
  1975年   6篇
  1974年   3篇
排序方式: 共有5998条查询结果,搜索用时 31 毫秒
31.
采用放射性配基结合分析法,现察内毒大致大鼠急性肺损伤时肺β-肾上腺素能受体(β-AR)的变化。分别用荧光偏振法和高效液相色谱测定肺组织细胞膜脂流动性和磷脂含量。结果显示:(1)静脉注射内毒素后4h,大鼠肺β-AR的最大结合容量明显降低,较对照组减少47%;(2)内毒素组肺膜脂流动性和磷脂含量均明显降低,同时伴有肺组织磷脂酶A2(PLA2)活性升高。提示:(1)β-AR下调导致其介导的功能减弱,在内毒素诱导的大鼠急性肺损伤发病机理中起一定作用;(2)PLA2激活是膜磷脂减少的重要原因,后者可导致膜脂流动性降低,结果引起β-AR的侧向扩散和旋转运劝减弱,从而减少β-AR与配基结合的机率,出现β-AK下调。  相似文献   
32.
观察了hFPIL6/2对6.5Gyγ线照射NIH小鼠第10天造血功能恢复的影响。结果表明:照射小鼠连续4d给予hFPIL6/2250μg·kg-1·d-1,其脾重、CFU-8、骨髓有核细胞数及CM-CFU分别比对照组增加59.0%、278.5%、57.9%和138.2%,统计学处理均有显著差异;对此四项指标的改善也明显优于25μg组。另外,250μg剂量组小鼠外周血象30d的动态观察结果表明,hFPIL6/2不但能明显提高红细胞和血红蛋白的最低值,而且能使血小板的恢复提前。提示hFPIL6/2在促进血小板生成和促进红系造血方面可能具有良好的应用前景。  相似文献   
33.
杭绮  毛树坚 《动物学研究》1993,14(4):367-373
以草鱼ZC7901细胞株为材料,观察鱼类细胞从间期染色质到中期染色体的包装过程。主要通过(1)分裂期与间期细胞融合,诱导染色体早熟凝集;(2)染色体“伸长”处理;(3)培养细胞的低渗处理;(4)染色质辅展等方法,制作染色体标本,进行扫描和透射电镜观察。观察表明,鱼类染色质的基本结构与哺乳类细胞相同,也是直径约10nm的核丝。染色体的色装有两种形式:一种是多级螺旋化形成直径约300nm的染色单体,  相似文献   
34.
35.
棉花枯萎病菌多聚半乳糖醛酸内切酶在pH大于7时不稳定,故对它进行多种化学修饰而又不影响其活性,必须在pHd小于7的体系中进行。本文报道将PGAUase在还原剂存在下,与稀酸处理的Sepharose 4B交联,获得较高活力的固定化酶。固定化酶催化动力学表明,最适pH为4,4,最适温度为55℃,在pH1至8.0范围内稳定。和溶液酶比较,对热稳定性提高,但对碱稳定性下降。以多聚半乳糖醛酸为底物,Km为0.27mmol/L,Vmax为66.67nmol/L·min,均大于溶液酶(Km=0.07mmol/L,Vmax=28.00nmol/L·min)。在pH4.8,30℃,聚半乳糖醛酸在固相酶的柱中循环水解不同的时间降解产物经圆盘电泳和等电聚焦测定,得到不同大小的寡糖片段混合物,证明固相酶和溶液酶的作用方式相同,同时使以酶解法制备一定大小的有生物活性的寡糖分子成为可能。  相似文献   
36.

Aim

Understanding how species' traits and environmental contexts relate to extinction risk is a critical priority for ecology and conservation biology. This study aims to identify and explore factors related to extinction risk between herbaceous and woody angiosperms to facilitate more effective conservation and management strategies and understand the interactions between environmental threats and species' traits.

Location

China.

Taxon

Angiosperms.

Methods

We obtained a large dataset including five traits, six extrinsic variables, and 796,118 occurrence records for 14,888 Chinese angiosperms. We assessed the phylogenetic signal and used phylogenetic generalized least squares regressions to explore relationships between extinction risk, plant traits, and extrinsic variables in woody and herbaceous angiosperms. We also used phylogenetic path analysis to evaluate causal relationships among traits, climate variables, and extinction risk of different growth forms.

Results

The phylogenetic signal of extinction risk differed among woody and herbaceous species. Angiosperm extinction risk was mainly affected by growth form, altitude, mean annual temperature, normalized difference vegetation index, and precipitation change from 1901 to 2020. Woody species' extinction risk was strongly affected by height and precipitation, whereas extinction risk for herbaceous species was mainly affected by mean annual temperature rather than plant traits.

Main conclusions

Woody species were more likely to have higher extinction risks than herbaceous species under climate change and extinction threat levels varied with both plant traits and extrinsic variables. The relationships we uncovered may help identify and protect threatened plant species and the ecosystems that rely on them.  相似文献   
37.
在赣榆县厉庄以大金鸡菊、紫穗槐和红柳三种经济植物进行了地埂利用型式试验,取得了比较明显的水土保持效果和改善农田小环境的生态效益。栽植后第三年植物覆盖率达90%或100%;地面蒸发量减少15.2~17.7%;截留降水量为0.5~0.7mm;大气相对湿度提高3.7~5.4%;土壤养分也有不同程度的增加。经济效益估测每亩地埂可收到300~600元,比种黄豆高5~9倍。效益最好的是红柳,大金鸡菊次之,紫穗槐较低。  相似文献   
38.
Phosphite is a stable phosphorus compound that, together with phosphate, made up a substantial part of the total phosphorus content of the prebiotic Earth's crust. Oxidation of phosphite to phosphate releases electrons at an unusually low redox potential (−690 mV at pH 7.0). Numerous aerobic and anaerobic bacteria use phosphite as a phosphorus source and oxidise it to phosphate for synthesis of nucleotides and other phosphorus-containing cell constituents. Only two pure cultures of strictly anaerobic bacteria have been isolated so far that use phosphite as an electron donor in their energy metabolism, the Gram-positive Phosphitispora fastidiosa and the Gram-negative Desulfotignum phosphitoxidans. The key enzyme of this metabolism is an NAD+-dependent phosphite dehydrogenase enzyme that phosphorylates AMP to ADP. These phosphorylating phosphite dehydrogenases were found to be related to nucleoside diphosphate sugar epimerases. The produced NADH is channelled into autotrophic CO2 fixation via the Wood-Ljungdahl (CO-DH) pathway, thus allowing for nearly complete assimilation of the substrate electrons into bacterial biomass. This extremely efficient type of electron flow connects energy and carbon metabolism directly through NADH and might have been important in the early evolution of life when phosphite was easily available on Earth.  相似文献   
39.
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease that seriously threatens the health of patients. The pathogenesis of IPF is still unclear, and there is a lack of effective therapeutic drugs. Myofibroblasts are the main effector cells of IPF, leading to excessive deposition of extracellular matrix (ECM) and promoting the progression of fibrosis. Inhibiting the excessive activation and relieving autophagy blockage of myofibroblasts is the key to treat IPF. PI3K/Akt/mTOR pathway plays a key regulatory role in promoting fibroblast activation and autophagy inhibition in lung fibrosis. Duvelisib is a PI3K inhibitor that can simultaneously inhibit the activities of PI3K-δ and PI3K-γ, and is mainly used for the treatment of relapsed/refractory chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma tumour (SLL). In this study, we aimed to examine the effects of Duvelisib on pulmonary fibrosis. We used a mouse model of bleomycin-induced pulmonary fibrosis to evaluate the effects of Duvelisib on pulmonary fibrosis in vivo and further explored the potential pharmacological mechanisms of Duvelisib in lung fibroblasts in vitro. The in vivo experiments showed that Duvelisib significantly alleviated bleomycin-induced collagen deposition and improved pulmonary function. In vitro and in vivo pharmacological experiments showed that Duvelisib dose-dependently suppressed lung fibroblast activation and improved autophagy inhibition by inhibiting the phosphorylation of PI3K, Akt and mTOR. Our results indicate that Duvelisib can alleviate the severity of pulmonary fibrosis and provide potential drugs for the treatment of pulmonary fibrosis.  相似文献   
40.
Nonalcoholic fatty liver disease (NAFLD) is a strong stimulant of cardiovascular diseases, affecting one-quarter of the world's population. TBC1 domain family member 25 (TBC1D25) regulates the development of myocardial hypertrophy and cerebral ischemia–reperfusion injury; however, its effect on NAFLD/nonalcoholic steatohepatitis (NASH) has not been reported. In this study, we demonstrated that TBC1D25 expression is upregulated in NASH. TBC1D25 deficiency aggravated hepatic steatosis, inflammation, and fibrosis in NASH. In vitro tests revealed that TBC1D25 overexpression restrained NASH responses. Subsequent mechanistic validation experiments demonstrated that TBC1D25 interfered with NASH progression by inhibiting abnormal lipid accumulation and inflammation. TBC1D25 deficiency significantly promoted NASH occurrence and development. Therefore, TBC1D25 may potentially be used as a clinical therapeutic target for NASH treatment.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号